MediPal Holdings Corporation
MEPDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6 | $945 | $864 | $983 |
| % Growth | -99.3% | 9.4% | -12% | – |
| Cost of Goods Sold | $6 | $880 | $803 | $915 |
| Gross Profit | $0 | $65 | $62 | $68 |
| % Margin | 6.5% | 6.8% | 7.1% | 6.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $41 | $42 | $40 |
| SG&A Expenses | $0 | $47 | $48 | $46 |
| Sales & Mktg Exp. | $0 | $6 | $6 | $6 |
| Other Operating Expenses | $0 | $3 | $3 | $3 |
| Operating Expenses | $0 | $51 | $51 | $50 |
| Operating Income | $0 | $14 | $10 | $18 |
| % Margin | 1.2% | 1.5% | 1.2% | 1.9% |
| Other Income/Exp. Net | $0 | $5 | $1 | $8 |
| Pre-Tax Income | $0 | $19 | $11 | $26 |
| Tax Expense | $0 | $6 | $4 | $9 |
| Net Income | $0 | $10 | $4 | $15 |
| % Margin | 1.3% | 1% | 0.5% | 1.5% |
| EPS | 0.41 | 46.17 | 19.43 | 69.78 |
| % Growth | -99.1% | 137.6% | -72.2% | – |
| EPS Diluted | 0.41 | 46.17 | 19.43 | 69.78 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $3 | $5 | $4 |
| EBITDA | $0 | $17 | $15 | $23 |
| % Margin | 2.7% | 1.8% | 1.7% | 2.3% |